127 related articles for article (PubMed ID: 33844639)
1. PGAM1 and TP53 mRNA levels in canine mammary carcinomas - Short communication.
Maués T; Oliveira TF; El-Jaick KB; Figueiredo AMS; Ferreira MLG; Ferreira AMR
Acta Vet Hung; 2021 Apr; 69(1):50-54. PubMed ID: 33844639
[TBL] [Abstract][Full Text] [Related]
2. TP53 gene expression levels and tumor aggressiveness in canine mammary carcinomas.
Oliveira TF; Maués T; Ramundo MS; Figueiredo AMS; de Mello MFV; El-Jaick KB; Ferreira MLG; Ferreira AMR
J Vet Diagn Invest; 2017 Nov; 29(6):865-868. PubMed ID: 28754073
[TBL] [Abstract][Full Text] [Related]
3. Phosphoglycerate mutase 1 regulates dNTP pool and promotes homologous recombination repair in cancer cells.
Qu J; Sun W; Zhong J; Lv H; Zhu M; Xu J; Jin N; Xie Z; Tan M; Lin SH; Geng M; Ding J; Huang M
J Cell Biol; 2017 Feb; 216(2):409-424. PubMed ID: 28122957
[TBL] [Abstract][Full Text] [Related]
4. PGAM1 regulates the glycolytic metabolism of SCs in tibetan sheep and its influence on the development of SCs.
An X; Li T; Chen N; Wang H; Wang X; Ma Y
Gene; 2021 Dec; 804():145897. PubMed ID: 34418471
[TBL] [Abstract][Full Text] [Related]
5. Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation.
Hitosugi T; Zhou L; Fan J; Elf S; Zhang L; Xie J; Wang Y; Gu TL; Alečković M; LeRoy G; Kang Y; Kang HB; Seo JH; Shan C; Jin P; Gong W; Lonial S; Arellano ML; Khoury HJ; Chen GZ; Shin DM; Khuri FR; Boggon TJ; Kang S; He C; Chen J
Nat Commun; 2013; 4():1790. PubMed ID: 23653202
[TBL] [Abstract][Full Text] [Related]
6. Phosphoglycerate mutase 1 that is essential for glycolysis may act as a novel metabolic target for predicating poor prognosis for patients with gastric cancer.
Wei C; Xie J; Yuan X; Luo Y; Xiao Y; Liao W; Jiang Z
J Clin Lab Anal; 2022 Nov; 36(11):e24718. PubMed ID: 36181311
[TBL] [Abstract][Full Text] [Related]
7. PGAM1 Promotes Glycolytic Metabolism and Paclitaxel Resistance via Pyruvic Acid Production in Ovarian Cancer Cells.
Feng Y; Zhang X; Zhang S; Xu S; Chen X; Zhou C; Xi Y; Xie X; Lu W
Front Biosci (Landmark Ed); 2022 Sep; 27(9):262. PubMed ID: 36224008
[TBL] [Abstract][Full Text] [Related]
8. The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications.
Jiang X; Sun Q; Li H; Li K; Ren X
Int J Cancer; 2014 Nov; 135(9):1991-6. PubMed ID: 24285383
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics simulation reveals how phosphorylation of tyrosine 26 of phosphoglycerate mutase 1 upregulates glycolysis and promotes tumor growth.
Wang Y; Cai WS; Chen L; Wang G
Oncotarget; 2017 Feb; 8(7):12093-12107. PubMed ID: 28076845
[TBL] [Abstract][Full Text] [Related]
10. Identification of tumour-associated and germ line p53 mutations in canine mammary cancer.
Veldhoen N; Watterson J; Brash M; Milner J
Br J Cancer; 1999 Oct; 81(3):409-15. PubMed ID: 10507764
[TBL] [Abstract][Full Text] [Related]
11. Phosphoglycerate mutase 1 in cancer: A promising target for diagnosis and therapy.
Sharif F; Rasul A; Ashraf A; Hussain G; Younis T; Sarfraz I; Chaudhry MA; Bukhari SA; Ji XY; Selamoglu Z; Ali M
IUBMB Life; 2019 Oct; 71(10):1418-1427. PubMed ID: 31169978
[TBL] [Abstract][Full Text] [Related]
12. Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity.
Zhang D; Jin N; Sun W; Li X; Liu B; Xie Z; Qu J; Xu J; Yang X; Su Y; Tang S; Han H; Chen D; Ding J; Tan M; Huang M; Geng M
Oncogene; 2017 May; 36(20):2900-2909. PubMed ID: 27991922
[TBL] [Abstract][Full Text] [Related]
13. Phosphoglyceric acid mutase-1 contributes to oncogenic mTOR-mediated tumor growth and confers non-small cell lung cancer patients with poor prognosis.
Sun Q; Li S; Wang Y; Peng H; Zhang X; Zheng Y; Li C; Li L; Chen R; Chen X; Bai W; Jiang X; Liu L; Wei F; Wang B; Zhang Y; Li H; Ren X; Zhang H
Cell Death Differ; 2018 Jun; 25(6):1160-1173. PubMed ID: 29362480
[TBL] [Abstract][Full Text] [Related]
14. Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth.
Hitosugi T; Zhou L; Elf S; Fan J; Kang HB; Seo JH; Shan C; Dai Q; Zhang L; Xie J; Gu TL; Jin P; Alečković M; LeRoy G; Kang Y; Sudderth JA; DeBerardinis RJ; Luan CH; Chen GZ; Muller S; Shin DM; Owonikoko TK; Lonial S; Arellano ML; Khoury HJ; Khuri FR; Lee BH; Ye K; Boggon TJ; Kang S; He C; Chen J
Cancer Cell; 2012 Nov; 22(5):585-600. PubMed ID: 23153533
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic value and functional roles of phosphoglycerate mutase 1 in glioma.
Xu Z; Gong J; Wang C; Wang Y; Song Y; Xu W; Liu Z; Liu Y
Oncol Rep; 2016 Oct; 36(4):2236-44. PubMed ID: 27572934
[TBL] [Abstract][Full Text] [Related]
16. Mouse phosphoglycerate mutase M and B isozymes: cDNA cloning, enzyme activity assay and mapping.
Zhang J; Yu L; Fu Q; Gao J; Xie Y; Chen J; Zhang P; Liu Q; Zhao S
Gene; 2001 Feb; 264(2):273-9. PubMed ID: 11250083
[TBL] [Abstract][Full Text] [Related]
17. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
18. Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors.
Lee CH; Kweon OK
J Vet Sci; 2002 Dec; 3(4):321-5. PubMed ID: 12819382
[TBL] [Abstract][Full Text] [Related]
19. Proteomics identification of PGAM1 as a potential therapeutic target for urothelial bladder cancer.
Peng XC; Gong FM; Chen Y; Qiu M; Cheng K; Tang J; Ge J; Chen N; Zeng H; Liu JY
J Proteomics; 2016 Jan; 132():85-92. PubMed ID: 26655504
[TBL] [Abstract][Full Text] [Related]
20. Reduced canine BRCA2 expression levels in mammary gland tumors.
Yoshikawa Y; Morimatsu M; Ochiai K; Ishiguro-Oonuma T; Wada S; Orino K; Watanabe K
BMC Vet Res; 2015 Jul; 11():159. PubMed ID: 26202431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
